Provided by Tiger Trade Technology Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

79.03
+0.56000.71%
Post-market: 79.030.00000.00%19:57 EDT
Volume:270.11K
Turnover:21.38M
Market Cap:6.17B
PE:79.83
High:79.93
Open:78.28
Low:78.01
Close:78.47
52wk High:82.94
52wk Low:32.89
Shares:78.02M
Float Shares:40.19M
Volume Ratio:0.54
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9900
EPS(LYR):0.7500
ROE:14.04%
ROA:8.05%
PB:9.43
PE(LYR):105.37

Loading ...

Kiniksa Q2 FY26 Net Income Rises 42.7% to $25.4 Million; Revenue Climbs 55.4% to $243.6 Million

Reuters
·
Jul 28

Kiniksa Pharmaceuticals Q2 EPS $0.30 Beats $0.27 Estimate, Sales $243.600M Beat $225.457M Estimate

Benzinga Earnings
·
Jul 28

Kiniksa Pharmaceuticals Q2 EPS USD 0.3

THOMSON REUTERS
·
Jul 28

Kiniksa Pharmaceuticals Q2 Product Revenue USD 243.6 Million

THOMSON REUTERS
·
Jul 28

Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution

THOMSON REUTERS
·
Jul 28

Kiniksa Pharmaceuticals International, PLC Expected to Post Earnings of 30 Cents a Share - Earnings Preview

Reuters
·
Jul 24

Kiniksa Pharmaceuticals International (KNSA) Joins Russell Indexes, Is The Stock Fully Valued?

Simply Wall St.
·
Jul 09

Kiniksa Files Form 3 for Chief Strategy Officer Dhiraj H. Malkani

Reuters
·
Jul 07

Kiniksa Pharmaceuticals is Maintained at Outperform by Wedbush

Dow Jones
·
Jun 29

Kiniksa price target raised to $72 from $59 at Wedbush

TIPRANKS
·
Jun 29

Kiniksa Pharmaceuticals International, Plc : Wedbush Raises Target Price to $72 from $59

THOMSON REUTERS
·
Jun 29

Wedbush Raises Price Target on Kiniksa Pharmaceuticals International to $72 From $59, Keeps Outperform Rating

MT Newswires Live
·
Jun 29

US High Growth Tech Stocks to Watch

Simply Wall St.
·
Jun 24

Kiniksa Pharmaceuticals International (KNSA) Stock Could Be 18% Undervalued After Strong Buy Upgrade

Simply Wall St.
·
Jun 17

Kiniksa Pharmaceuticals held annual shareholder meeting

Reuters
·
May 30

Kiniksa Pharma to present at Jefferies Global Healthcare Conference fireside chat

Reuters
·
May 30

Kiniksa shareholders waive share conversion rights above 49.9% voting stake

Reuters
·
May 27

Kiniksa Pharmaceuticals announces annual shareholder meeting

Reuters
·
May 09

Kiniksa publishes 2025 annual report

Reuters
·
May 09

Kiniksa CMO John F. Paolini disposes 58,424 shares for $3.15 million

Reuters
·
May 06